DDIT3 and metabolic dysfunction-associated steatohepatitis: Overall, this study improves our understanding of the liver- and gene-specific role of Txnip in NASH development and will significantly accelerate the development of novel therapeutic strategies that targeting NEDD4L-TXNIP-CHOP axis to treat NASH.